Company Filing History:
1 out of 3 
1 out of 1 Years Active: 1999
Title: Anna Magdalene Wobus: Pioneering Insights in Embryotoxicity Testing
Introduction
Anna Magdalene Wobus, an innovative inventor based in Gatersleben, Germany, has made significant contributions to the field of embryotoxicity testing. With a total of two patents to her name, her work has had a profound impact on understanding the effects of various agents on embryonic development.
Latest Patents
Wobus's latest patents focus on groundbreaking methodologies for assessing embryotoxic and teratogenic agents. These patents include an in vitro test using embryonal cardiac muscle cells, which plays a crucial role in evaluating the safety of substances that may affect fetal development. Her research has established new benchmarks in the study of developmental toxicity.
Career Highlights
Throughout her career, Anna has worked at notable institutions such as the Institut für Pflanzenengenetik und Kulturpflanzenforschung, contributing valuable insights and advancing research in plant genetics and toxicology. Her academic and professional undertakings reflect her commitment to innovation in scientific research.
Collaborations
Wobus has collaborated with esteemed colleagues, including Wolfgang-Michael Franz. Their joint efforts have fostered a collaborative environment that promotes innovation and success in their research endeavors, further driving the advancement of knowledge in the field.
Conclusion
In summary, Anna Magdalene Wobus exemplifies the spirit of innovation in scientific research. Her patents and collaborations have positioned her as a key figure in the study of embryotoxicity, ensuring that her contributions will have a lasting impact on the field and beyond.